Chemokine receptors--the next therapeutic target for HIV?

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Receptors and Channels

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 11918345
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antagonists of the human CCR5 receptor as anti-HIV-1 agents. part 1: discovery and initial structure-activity relationships for 1 -amino-2-phenyl-4-(piperidin-1-yl)butanes.

  2001cited by this paper
• Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure-activity relationships for substituted 2-Aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes.

  2001cited by this paper
• Chemokines and viruses: the dearest enemies.

  2000cited by this paper
• Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent

  2000cited by this paper
• A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5.

  2000cited by this paper
• Identification and Characterization of a Potent, Selective, and Orally Active Antagonist of the CC Chemokine Receptor-1*

  2000cited by this paper
• Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety.

  2000cited by this paper
• Endocytosis and Recycling of the HIV Coreceptor Ccr5

  2000cited by this paper
• Induction of experimental autoimmune encephalomyelitis in C57BL / 6 mice deficient in either the chemokine macrophage inflammatory protein‐1α or its CCR5 receptor

  2000cited by this paper
• Mice with a Selective Deletion of the CC Chemokine Receptors 5 or 2 Are Protected from Dextran Sodium Sulfate-Mediated Colitis: Lack of CC Chemokine Receptor 5 Expression Results in a NK1.1+ Lymphocyte-Associated Th2-Type Immune Response in the Intestine1

  2000cited by this paper
• Chemokines: a new classification system and their role in immunity.

  2000cited by this paper
• Molecular modeling and site‐directed mutagenesis of CCR5 reveal residues critical for chemokine binding and signal transduction

  2000cited by this paper
• A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity.

  1999cited by this paper
• Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.

  1999cited by this paper
• CD4-Immunoglobulin G2 Protects Hu-PBL-SCID Mice against Challenge by Primary Human Immunodeficiency Virus Type 1 Isolates

  1998cited by this paper
• Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC)

  1998cited by this paper
• A new classification for HIV-1

  1998cited by this paper
• A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation

  1998cited by this paper
• Determinants for Sensitivity of Human Immunodeficiency Virus Coreceptor CXCR4 to the Bicyclam AMD3100

  1998cited by this paper
• AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

  1998cited by this paper
• Definition, function and pathophysiological significance of chemokine receptors.

  1998cited by this paper
• The CC Chemokine I-309 Inhibits CCR8-dependent Infection by Diverse HIV-1 Strains*

  1998cited by this paper
• Chemokines--chemotactic cytokines that mediate inflammation.

  1998cited by this paper
• A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.

  1997cited by this paper
• Two Orphan Seven-Transmembrane Segment Receptors Which Are Expressed in CD4-positive Cells Support Simian Immunodeficiency Virus Infection

  1997cited by this paper
• Chemokines.

  1997cited by this paper
• Phorbol Esters and SDF-1 Induce Rapid Endocytosis and Down Modulation of the Chemokine Receptor CXCR4

  1997cited by this paper
• Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4.

  1997cited by this paper
• Receptor-mediated Endocytosis of CC-chemokines*

  1997cited by this paper
• Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4

  1997cited by this paper
• Expression cloning of new receptors used by simian and human immunodeficiency viruses

  1997cited by this paper
• Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

  1997cited by this paper
• Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.

  1996cited by this paper
• The role of a mutant CCR5 allele in HIV–1 transmission and disease progression

  1996cited by this paper
• Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry

  1996cited by this paper
• Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

  1996cited by this paper
• Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

  1995cited by this paper
• Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100

  1994cited by this paper
• Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression

  1994cited by this paper
• Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.

  1994cited by this paper
• Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.

  1992cited by this paper
• Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1.

  1992cited by this paper
• High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.

  1990cited by this paper
• The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

  1986cited by this paper

• Small molecules anti-HIV therapeutics targeting CXCR4.

  2008cites this paper
• The HIV entry inhibitors revisited.

  2006cites this paper
• Cytokines in Mycoplasma pneumoniae infections.

  2004cites this paper
• Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs.

  2004cites this paper
• Inhibition of the human chemokine receptor CCR5 by variecolin and variecolol and isolation of four new variecolin analogues, emericolins A-D, from Emericella aurantiobrunnea.

  2004cites this paper
• Phenolic derivatives from Wigandia urens with weak activity against the chemokine receptor CCR5.

  2003cites this paper
• 10-Methoxydihydrofuscin, fuscinarin, and fuscin, novel antagonists of the human CCR5 receptor from Oidiodendron griseum.

  2003cites this paper
• Corruption of host seven-transmembrane proteins by pathogenic microbes: a common theme in animals and plants?

  2003cites this paper
• The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype C

  2003cites this paper